E-LIB Suche - Ergebnisse für: Tsai, T. F.

1

Application of polycolloid-releasing substrate to remediate..:

Tsai, T.T. ; Liu, J.K. ; Chang, Y.M...
Journal of Hazardous Materials. 268 (2014) - p. 92-101 , 2014

Link: https://doi.org/10.1016/..

2

Polybenzobisthiazoles with crosslinking sites for improved ..:

Dang, T.D. ; Wang, C.S. ; Click, W.E....
Polymer. 38 (1997) 3 - p. 621-629 , 1997

Link: https://doi.org/10.1016/..

3

Targeted immunotherapy for moderate-to-severe palmoplantar ..:

Tsai, Y.C. ; Hsu, Francis LT. ; Tsai, T.F.
Journal of the American Academy of Dermatology. , 2024

Link: https://doi.org/10.1016/..

4

Elevation of CISD2 attenuates atrial aging:

Yeh, C H ; Shen, Z Q ; Chou, Y J...
European Heart Journal. 44 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

5

Haemorrhagic bullous pyoderma gangrenosum followingCOVID‐19..:

Hung, Y.‐T. ; Chung, W.‐H. ; Tsai, T.‐F..
Journal of the European Academy of Dermatology and Venereology. 36 (2022) 8 - p. , 2022

Link: https://doi.org/10.1111/..

6

Secukinumab 2‐weekly vs. 4‐weekly dosing in plaque‐type pso..:

Tsai, T.‐F.
British Journal of Dermatology. 184 (2021) 5 - p. 791-792 , 2021

Link: https://doi.org/10.1111/..

7

Physio-Cognitive Decline Syndrome as the Phenotype and Trea..:

Chung, C.-P. ; Lee, W.-J. ; Peng, L.-N....
The Journal of nutrition, health and aging. 25 (2021) 10 - p. 1179-1189 , 2021

Link: https://doi.org/10.1007/..

8

ABCB1 in dermatology: roles in skin diseases and their trea..:

Weng, H. J. ; Tsai, T. F.
Journal of Molecular Medicine. 99 (2021) 11 - p. 1527-1538 , 2021

Link: https://doi.org/10.1007/..

9

Safety in moderate‐to‐severe plaque psoriasis patients with..:

Puig, L. ; Tsai, T.‐F. ; Bhutani, T....
Journal of the European Academy of Dermatology and Venereology. 34 (2020) 8 - p. 1744-1749 , 2020

Link: https://doi.org/10.1111/..

10

Secukinumab in patients with psoriasis who have responded i..:

Tsai, T.‐F.
British Journal of Dermatology. 183 (2020) 1 - p. 7-8 , 2020

Link: https://doi.org/10.1111/..

11

Oral disease-modifying antirheumatic drugs and immunosuppre..:

Tsai, Y. C. ; Tsai, T. F.
Therapeutic Advances in Musculoskeletal Disease. 12 (2020) - p. 1759720X2094729 , 2020

Link: https://doi.org/10.1177/..

12

PRO18 Incidence, Mortality, Hospitalizations, and Expenditu..:

Chang, C.J. ; Chiu, H.Y. ; YuJr, L..
Value in Health Regional Issues. 22 (2020) - p. S98 , 2020

Link: https://doi.org/10.1016/..

13

PBI1 The Psoriasis Study of Health Outcomes (PSOHO) in Biol..:

Costanzo, A. ; Pinter, A. ; Lynde, C....
Value in Health. 23 (2020) - p. S410 , 2020

Link: https://doi.org/10.1016/..

14

Clinical experience of ixekizumab in the treatment of patie..:

Lo, Y. ; Tsai, T.‐F.
British Journal of Dermatology. 181 (2019) 5 - p. 1106-1107 , 2019

Link: https://doi.org/10.1111/..

15

Juvenile‐onset pustular psoriasis: case series and literatu..:

Huang, Y.‐W. ; Tsai, T.‐F.
British Journal of Dermatology. 182 (2019) 3 - p. 816-817 , 2019

Link: https://doi.org/10.1111/..